Compare Kingsoft Cloud Holdings Limited (KC) vs Repligen Corporation Common Stock (RGEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kingsoft Cloud Holdings Limited vs Repligen Corporation Common Stock — how do they compare? Kingsoft Cloud Holdings Limited trades at $8.63 (market cap $2.80B), while Repligen Corporation Common Stock trades at $180.48 (market cap $11.31B). The key difference: Repligen Corporation Common Stock is far larger — about 4× Kingsoft Cloud Holdings Limited's market cap, and Repligen Corporation Common Stock is trading nearer its 52-week high, Kingsoft Cloud Holdings Limited nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Kingsoft Cloud Holdings Limited for 12 Days and Repligen Corporation Common Stock for 0 Days on average.
| KC | RGEN | |
|---|---|---|
Market Cap | $2.80B | $11.31B |
Volume | 2,145,784 | 1,216,919 |
Sector | Technology | Health |
52-Week High | $18.21 | $194.57 |
52-Week Low | $8.58 | $102.87 |
Typical Hold Time | 12 Days | 0 Days |
Enterprise Value | $3.12B | $11.20B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Kingsoft Cloud (KC) trades at $8.48, down 9.01% in the last session amid bearish technical signals. The stock shows mixed fundamentals with strong revenue growth (30.8% y/y in Q2 2026) and improving gross margins, but remains unprofitable with negative net income margins. Recent earnings beats and analyst optimism (70% buy ratings) contrast with weak technical indicators and cash flow challenges projected for 2026.
The outlook remains bifurcated - strong AI cloud growth and analyst price targets suggesting 60% upside potential offer opportunity, while persistent losses, negative cash flow projections, and bearish technical momentum present significant risk. Investors should weigh the company's positioning in China's expanding AI ecosystem against execution challenges and macroeconomic headwinds.
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kingsoft Cloud Holdings Limited
Kingsoft Cloud is a leading independent cloud service provider in China. It offers a comprehensive suite of cloud products and solutions tailored for industries like gaming, video streaming, and financial services.
Read more on KC →About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →
